Tate Rarick
August 2024
Market Access Strategy
Access Realization is the art and science of helping healthcare system stakeholders navigate complex market access environments to ensure that their innovative medications reach as many appropriate patients as possible. The rise of complex specialty medications has created a widening gap between potential and realized market access due to an enormous increase in market access complexity.
Despite significant and continued investments in data, resources, and software tools, biopharma manufacturers of all sizes still struggle to overcome this complexity and reach the full potential of their products.
Already challenging, market access complexity continues to increase as new and innovative therapies continue to enter the market, resulting in a rise in rejected prescriptions that shows no sign of improving with time.
Market access challenges follow common patterns for most biopharma companies; two examples are listed below.
In response, biopharma companies have focused on enabling access through a combination of Patient Services and Access Realization.
Closing the growing Access Realization gap entails a coordinated multi-year and cross functional effort, but usually includes information and resources for:
While each biopharma company has its own unique footprint, the ecosystem of tools and partners typically involves:
Contact us or email to learn how we can help your team achieve your market access goals.